Jin Cai Li
Chief Executive Officer at WUXI XDC CAYMAN INC.
Profile
Jin Cai Li is currently the Chief Executive Officer & Executive Director at WuXi XDC Cayman, Inc. Prior to this, Dr. Li worked as a Staff Scientist at Diversa Corp.
and as a Scientist at Tanox, Inc. Dr. Li received an undergraduate degree from Tsinghua University in 1996 and a doctorate degree from the University of Maryland Medical Center in 2001.
Jin Cai Li active positions
Companies | Position | Start |
---|---|---|
WUXI XDC CAYMAN INC. | Chief Executive Officer | 2020-11-30 |
Former positions of Jin Cai Li
Companies | Position | End |
---|---|---|
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Corporate Officer/Principal | 2013-10-27 |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Corporate Officer/Principal | - |
Training of Jin Cai Li
Tsinghua University | Undergraduate Degree |
University of Maryland Medical Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
WUXI XDC CAYMAN INC. | Commercial Services |
Private companies | 2 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Diversa Corp.
Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry | Commercial Services |
- Stock Market
- Insiders
- Jin Cai Li